Skip to Main Content

Author Details

Fiorella Schischlik
National Cancer Institute, National Institutes of Health
2013
22
11
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38048593Transcriptional control of leukemogenesis by the chromatin reader SGF29.Blood2024
36789425Predicting tumor immune microenvironment and checkpoint therapy response of head & neck cancer patients from blood immune single-cell transcriptomics.bioRxiv2023
38076973Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues.bioRxiv2023
37295816CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity.J Immunother Cancer2023
35338126The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective.Nat Commun2022
35502318Synthetic lethality-based prediction of anti-SARS-CoV-2 targets.iScience2022
35015307PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.Am J Hematol2022
34983745Deconvolving Clinically Relevant Cellular Immune Cross-talk from Bulk Gene Expression Using CODEFACS and LIRICS Stratifies Patients with Melanoma to Anti-PD-1 Therapy.Cancer Discov2022
35153005Transcriptional configurations of myeloproliferative neoplasms.Int Rev Cell Mol Biol2022
32814349Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera.Blood2021
34525183Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.Blood2021
34545363Synthetic lethality-based prediction of anti-SARS-CoV-2 targets.bioRxiv2021
32824053Myelomonocytic Skewing In Vitro Discriminates Subgroups of Patients with Myelofibrosis with A Different Phenotype, A Different Mutational Profile and Different Prognosis.Cancers (Basel)2020
31133746MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation.Nat Genet2019
30237509Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking.Cell Death Differ2019
31064751Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms.Blood2019
30442766LZTR1 is a regulator of RAS ubiquitination and signaling.Science2018
28914569Mutations in myeloproliferative neoplasms - their significance and clinical use.Expert Rev Hematol2017
29089570Parallel genome-wide screens identify synthetic viable interactions between the BLM helicase complex and Fanconi anemia.Nat Commun2017
27389715Cooperation of germ line JAK2 mutations E846D and R1063H in hereditary erythrocytosis with megakaryocytic atypia.Blood2016
24161985A reversible gene trap collection empowers haploid genetics in human cells.Nat Methods2013
24325356Somatic mutations of calreticulin in myeloproliferative neoplasms.N Engl J Med2013
  • 1 - 22 of 22

Recommended Authors

Huntsman Cancer Institute, The University of Utah
Career Start Year 2017
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Washington University in St Louis
Career Start Year 2015
Number of shared co-authors 0
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2015
Number of shared co-authors 0
and Blood Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 0
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 2
Inner Mongolia University
Career Start Year 2010
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 1
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 0
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Adelaide Medical School, University of Adelaide
Career Start Year 2003
Number of shared co-authors 2
Oregon Health & Science University School of Medicine
Career Start Year 2002
Number of shared co-authors 1
Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 0
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 1
Washington University School of Medicine.
Career Start Year 2001
Number of shared co-authors 0
Washington University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 2
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 0
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 0
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 2
Washington University School of Medicine in St. Louis
Career Start Year 1994
Number of shared co-authors 2
The University of Chicago
Career Start Year 1994
Number of shared co-authors 3
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 3
Kyoto University
Career Start Year 1993
Number of shared co-authors 2
University of Paris
Career Start Year 1993
Number of shared co-authors 2
University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 1

Collaborators

Medical University of Vienna
Co-authored papers 11
National Cancer Institute
Co-authored papers 8
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 6
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 4
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 3
Karolinska Institutet.
Co-authored papers 3
The Scripps Research Institute
Co-authored papers 2
The Scripps Research Institute
Co-authored papers 2
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
CeMM Research Centre for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Co-authored papers 1
Beatson Institute for Cancer Research and the University of Glasgow
Co-authored papers 1
IMP-Institute of Molecular Pathology
Co-authored papers 1
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
University of Pittsburgh
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Center for Cancer Research, Comprehensive Cancer Centre, Medical University of Vienna
Co-authored papers 1
Co-authored papers 1
Leibniz Institute for Immunotherapy
Co-authored papers 1
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 1
Semmelweis University
Co-authored papers 1
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 1